In June I will be presenting at the MESA 2010 North American conference. The conference is going to be held in Dearborn, MI (near Detriot) hosted by Ford at their conference facility. I wanted to share the abstract here on my blog. I will be co-presenting with Kasper Larsen from Novo Nordisk and my colleague from NNE Pharmaplan, Asger Sharp-Johansen
The presentation shares our experiences from the current global MES rollout project at Novo Nordisk. This is an ongoing long term multi faceted project that involves a staggered deployment of a commercial MES software package to all of Novo Nordisk’s manufacturing sites.
Deploying a new manufacturing system is a complex and risky proposition for any company, rolling out such a system to multiple sites on a global scale may be even considered scary. In order to mitigate the risks and manage the complexity of this immense undertaking Novo Nordisk makes the best use of people and technology to evolve a best practice approach that is continually improved upon. This approach includes technical and organizational aspects that cover the complete life cycle of the manufacturing system’s deployment. In addition the “out-of-the-box” feature set of the software obviously did not suffice and navigating this predicament, coined as "Customize or Compromise", is another interesting topic.
Novo Nordisk is a global healthcare company with 87 years of innovation and leadership in diabetes care, haemophilia care, growth hormone therapy, and hormone replacement therapy. It has international production facilities and employs more than 29,300 employees in 76 countries.